Witzens-Harig M - Search Results

1

Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.

Witzens-Harig M, Waldherr R, Beimler J, Zeier M, Hansmann J, Ho AD, Goldschmidt H, Moehler T. Witzens-Harig M, et al. Ann Hematol. 2007 Dec;86(12):927-30. doi: 10.1007/s00277-007-0330-6. Epub 2007 Jun 29. Ann Hematol. 2007. PMID: 17605010 No abstract available.

2

Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A).

Li G, Hundemer M, Wolfrum S, Ho AD, Goldschmidt H, Witzens-Harig M. Li G, et al. Ann Hematol. 2006 Sep;85(9):583-90. doi: 10.1007/s00277-006-0137-x. Epub 2006 May 23. Ann Hematol. 2006. PMID: 16718496

3

In Burkitt lymphoma patients who relapse after induction with a short-intensive chemoimmunotherapy protocol, aggressive salvage chemotherapy therapy is ineffective: a single-center retrospective study.

Cremer M, Schwarzbich MA, Schöning T, Lisenko K, Ho AD, Witzens-Harig M. Cremer M, et al. Ann Hematol. 2017 Sep;96(9):1573-1575. doi: 10.1007/s00277-017-3044-4. Epub 2017 Jun 16. Ann Hematol. 2017. PMID: 28623395 No abstract available.

4

The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience.

Rohlfing S, Dietrich S, Witzens-Harig M, Hegenbart U, Schönland S, Luft T, Ho AD, Dreger P. Rohlfing S, et al. Ann Hematol. 2018 Jul;97(7):1241-1250. doi: 10.1007/s00277-018-3288-7. Epub 2018 Mar 16. Ann Hematol. 2018. PMID: 29549411

5

Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy.

Brandt J, Dietrich S, Meissner J, Neben K, Ho AD, Witzens-Harig M. Brandt J, et al. Leuk Lymphoma. 2010 Nov;51(11):2012-20. doi: 10.3109/10428194.2010.513749. Epub 2010 Sep 21. Leuk Lymphoma. 2010. PMID: 20858092

6

The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma.

Andresen S, Brandt J, Dietrich S, Memmer ML, Ho AD, Witzens-Harig M. Andresen S, et al. Leuk Lymphoma. 2012 Mar;53(3):386-93. doi: 10.3109/10428194.2011.613132. Epub 2011 Oct 10. Leuk Lymphoma. 2012. PMID: 21864036

7

High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.

Lisenko K, Sauer S, Bruckner T, Egerer G, Goldschmidt H, Hillengass J, Schmier JW, Shah S, Witzens-Harig M, Ho AD, Wuchter P. Lisenko K, et al. BMC Cancer. 2017 Feb 22;17(1):151. doi: 10.1186/s12885-017-3137-4. BMC Cancer. 2017. PMID: 28228122 Free PMC article.

8

Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.

Witzens-Harig M, Reiz M, Heiss C, Benner A, Hensel M, Neben K, Dreger P, Kraemer A, Ho AD. Witzens-Harig M, et al. Ann Hematol. 2009 Jan;88(1):51-7. doi: 10.1007/s00277-008-0560-2. Epub 2008 Jul 30. Ann Hematol. 2009. PMID: 18665360 Clinical Trial.

9

Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.

Wuchter P, Ran D, Bruckner T, Schmitt T, Witzens-Harig M, Neben K, Goldschmidt H, Ho AD. Wuchter P, et al. Biol Blood Marrow Transplant. 2010 Apr;16(4):490-9. doi: 10.1016/j.bbmt.2009.11.012. Epub 2009 Nov 17. Biol Blood Marrow Transplant. 2010. PMID: 19925876 Free article.

10

Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study.

Witzens-Harig M, Foá R, Di Rocco A, van Hazel G, Chamone DF, Rowe JM, Arcaini L, Poddubnaya I, Ho AD, Ivanova V, Vranovsky A, Thurley D, Oertel S. Witzens-Harig M, et al. Ann Hematol. 2014 Oct;93(10):1717-24. doi: 10.1007/s00277-014-2103-3. Epub 2014 May 14. Ann Hematol. 2014. PMID: 24824768 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters